Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 3/20 | 1.00 |
| ▸ | S1PR4 | O95977 | 2/20 | 1.00 |
| ▸ | S1PR3 | Q99500 | 2/20 | 1.00 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | S1PR2 | O95136 | 1/20 | 1.00 |
| ▸ | TSPO | P30536 | 1/20 | 1.00 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 1.00 |
| ▸ | SGPL1 | O95470 | 4/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | GMNN | O75496 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | GLA | P06280 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 2/20 | 0.60 |
| ▸ | CETP | P11597 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29438139 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL17482409 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL12766764 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL6055753 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL8736952 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL2561998 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL3517452 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL22910837 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL20798182 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 | |
| SCHEMBL29963390 | 1.00 | S1PR1 (1.00) | S1PR1S1PR4S1PR3S1PR5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19145 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3765486-B1 | REAGENTS AND METHODS WITH WNT AGONISTS AND BIOACTIVE LIPIDS FOR GENERATING AND EXPANDING CARDIOMYOCYTES | UNIV LELAND STANFORD JUNIOR (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260142011-A1 | PHARMACOKINETIC MODELING SYSTEMS FOR IMPROVED THERAPEUTIC DOSING | PROMETHEUS LABORATORIES INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026098644-A1 | TARGETED PROTEIN DEGRADATION AGENT, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 北京森妙生物科技有限公司 | 2026-05-15 | — | — | WO | claimed |
| US-12612401-B2 | Crystalline forms of an S1P receptor modulator | Oppilan Pharma Limited (GB) | 2026-04-28 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260097117-A1 | CONJUGATES | ORUM THERAPEUTICS INC (KR) | 2026-04-09 | — | — | US | claimed |
| US-20260092257-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEMATOPOIETIC PROGENITOR CELLS | TRAILHEAD BIOSYSTEMS INC. | 2026-04-02 | — | — | US | claimed |
| US-20260092064-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | OPPILAN PHARMA LTD. (GB) | 2026-04-02 | — | — | US | claimed |
| EP-4711446-A1 | CELL CULTURE PRODUCT AND USE THEREOF | GUANGXIU-GAOXIN LIFE SCIENCES CO., LTD. HUNAN (CN) | 2026-03-18 | — | — | EP | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-5663404-A | ANTITUMOR AGENTS; ANTIINFLAMMATORY AGENTS | ONCOMEMBRANE (US) | 1997-09-02 | — | — | US | claimed |
| EP-0671917-A4 | METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES. | BIOMEMBRANE INST (US) | 1997-06-18 | — | — | EP | claimed |
| US-5627171-A | SYNERGISTIC ANTIMETASTASIS AGENTS | ONCOMEMBRANE, INC. (US) | 1997-05-06 | — | — | US | claimed |
| WO-1996034879-A1 | IDENTIFICATION OF ENANTIOMERIC LIGANDS | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 1996-11-07 | — | — | WO | claimed |
| EP-0671917-A1 | METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES | ONCOMEMBRANE, INC. (US) | 1995-09-20 | — | — | EP | claimed |
| US-5430169-A | Method for preparation of sphingoid bases | THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-07-04 | — | — | US | claimed |
| US-5391800-A | Protecting hydroxyl groups of sphingosine, deprotecting C1, phosphorylating, deprotecting C3; free of L-threo isomer | THE BIOMEMBRANE INSTITUTE (US) | 1995-02-21 | — | — | US | claimed |
| US-5374616-A | A mixture consisting of insulin, epidermal and fibroblast growth factor, sphingosine and sphingosine-1-phosphate for DNA biosynthesis | GEORGETOWN UNIVERSITY (US) | 1994-12-20 | — | — | US | claimed |
| US-5260288-A | Administering an inflammation inhibitory amount | THE BIOMEMBRANE INSTITUTE (US) | 1993-11-09 | — | — | US | claimed |
| WO-1993019760-A1 | METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES | THE BIOMEMBRANE INSTITUTE (US) | 1993-10-14 | — | — | WO | claimed |